https://www.selleckchem.com/pr....oducts/resatorvid.ht
The final algorithm resulted in an AUC of 0.69 and a PPV of 3.4%. We developed a predictive algorithm to identify a patient population with increased risk of CDI over the next 2-12months. Our algorithm can be used prospectively with clinical and administrative data to facilitate the feasibility of conducting efficacy studies in a timely manner in an appropriate population. We developed a predictive algorithm to identify a patient population with increased risk of CDI over the next 2-12 months. Our algorithm can be used prospectively